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The incidence of Metabolic Syndrome, obesity and type 2 diabetes have
increased significantly during the 30 years. New studies suggest the
relationship between human exposure to some endocrine disruptors, with
the development of metabolic syndrome.
ENDOCRINE DISRUPTORS
Endocrine disruptors (EDs) are substances
or mixtures of exogenous substances
present generally in plastic components,
food and substances of anthropogenic
origin1.
They can act directly on hormonal receptors
like agonists or antagonists as seen in Figure 1.
Metabolic Syndrome is defined as a group
of the most dangerous risk factors for
cardiovascular disease and type 2 diabetes,
and currently affects 25% of the global
adult population2.
CONCLUSIONS
METABOLIC SYNDROME
There is a considerable evidence that MCDs contribute to the development of obesity, diabetes and metabolic syndrome.
In epidemiological studies is complex to determine a causality between a specific metabolism disruptor chemical and these pathologies.
The main problem is that it is currently impossible to identify population around the world that is not exposed to MCDs.
The alteration of the energetic metabolism, intake control, thyroid hormone production and the epigenetic changes seems to be de main
mechanisms of action in the development of metabolic syndrome and related diseases.
The aim of this project is to evaluate the current evidence of the exposure
to these substances and the prevalence of metabolic syndrome, as well as
defining the main mechanisms of action.
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Evidence in Humans
Figure 2: Main mechanisms of 
action of MDCs. 
Modified of Nadal et al., (2017)3.
Mechanisms of Action
Table 1. Main diseases associated with exposure to metabolism disruptor chemicals 
(MDCs) according to experimental studies.
Figure 1: Endocrine disruption concept.
Table 2. Main diseases associated with exposure to metabolism disruptor chemicals 
(MDCs) according to epidemiological studies.
